Literature DB >> 16537603

ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Craig S Miller1, Robert J Danaher, Robert J Jacob.   

Abstract

Viral genes sufficient and required for herpes simplex virus type 1 (HSV-1) reactivation were identified using neuronally differentiated PC12 cells (ND-PC12 cells) in which quiescent infections with wild-type and recombinant strains were established. In this model, the expression of ICP0, VP16, and ICP4 from adenovirus vectors was sufficient to reactivate strains 17+ and KOS. The transactivators induced similar levels of reactivation with KOS; however, 17+ responded more efficiently to ICP0. To identify viral transactivators required for reactivation, we examined quiescently infected PC12 cell cultures (QIF-PC12 cell cultures) established with HSV-1 deletion mutants R7910 (deltaICP0), KD6 (deltaICP4), and in1814, a virus containing an insertion mutation in VP16. Although growth of these mutant viruses was impaired in ND-PC12 cells, R7910 and in1814 reactivated at levels equivalent to or better than their respective parental controls following stress (i.e., heat or forskolin) treatment. After treatment with trichostatin A, in1814 and 17+ reactivated efficiently, whereas the F strain and R7910 reactivated inefficiently. In contrast, KD6 failed to reactivate. In experiments with the recombinant KM100, which contains the in1814 mutation in VP16 and the n212 mutation in ICP0, spontaneous and stress-induced reactivation was observed. However, two strains, V422 and KM110, which lack the acidic activation domain of VP16, did not reactivate above low spontaneous levels after stress. These results demonstrate that in QIF-PC12 cells ICP0 is not required for efficient reactivation of HSV-1, the acidic activation domain of VP16 is essential for stress-induced HSV-1 reactivation, and HSV-1 reactivation is modulated uniquely by different treatment constraints and phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537603      PMCID: PMC1440419          DOI: 10.1128/JVI.80.7.3360-3368.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  95 in total

1.  Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript.

Authors:  G C Perng; C Jones; J Ciacci-Zanella; M Stone; G Henderson; A Yukht; S M Slanina; F M Hofman; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.

Authors:  C M Preston; M J Nicholl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.

Authors:  W P Halford; C D Kemp; J A Isler; D J Davido; P A Schaffer
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway.

Authors:  R J Danaher; A D Savells-Arb; S A Black ; R J Jacob; C S Miller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

7.  Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice.

Authors:  Lawrence T Feldman; Aaron R Ellison; Cynthia C Voytek; Li Yang; Philip Krause; Todd P Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

8.  The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.

Authors:  C L Wilcox; R L Smith; R D Everett; D Mysofski
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; X Chen; D J Fink; R L Hendricks
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  23 in total

1.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

2.  Stress-induced cellular transcription factors expressed in trigeminal ganglionic neurons stimulate the herpes simplex virus 1 ICP0 promoter.

Authors:  Devis Sinani; Ethan Cordes; Aspen Workman; Prasanth Thunuguntia; Clinton Jones
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  CTCF occupation of the herpes simplex virus 1 genome is disrupted at early times postreactivation in a transcription-dependent manner.

Authors:  Monica K Ertel; Amy L Cammarata; Rebecca J Hron; Donna M Neumann
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.

Authors:  Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.

Authors:  Ta-Chiang Liu; Pedro Castelo-Branco; Samuel D Rabkin; Robert L Martuza
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

7.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  DNA damage promotes herpes simplex virus-1 protein expression in a neuroblastoma cell line.

Authors:  Ketna Volcy; Nigel W Fraser
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

9.  Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Authors:  Tracy Terry-Allison; Colton A Smith; Neal A DeLuca
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes.

Authors:  Roger D Everett; Marie-Laure Parsy; Anne Orr
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.